202 related articles for article (PubMed ID: 27677902)
21. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in general inhabitants in non-adult T-cell leukemia (ATL)-endemic Hokkaido, Japan.
Kwon KW; Yano M; Sekiguchi S; Iwanaga M; Fujiwara S; Oikawa O; Sugiura M; Imai S; Osato T
In Vivo; 1994; 8(6):1011-4. PubMed ID: 7772728
[TBL] [Abstract][Full Text] [Related]
22. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F
Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675
[TBL] [Abstract][Full Text] [Related]
23. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Line Immunoassay to Detect HTLV-1 Infection in an Endemic Area, Southwestern Japan; Comparison with Polymerase Chain Reaction and Western Blot.
Umeki K; Umekita K; Hashikura Y; Yamamoto I; Kubo K; Nagatomo Y; Okayama A
Clin Lab; 2017 Feb; 63(2):227-233. PubMed ID: 28182361
[TBL] [Abstract][Full Text] [Related]
25. Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki.
Chiyoda S; Kinoshita K; Egawa S; Inoue J; Watanabe K; Ifuku M
Intern Med; 2001 Jan; 40(1):14-7. PubMed ID: 11201362
[TBL] [Abstract][Full Text] [Related]
26. Human T-cell lymphotropic virus type 1 (HTLV-1) and lymphoid malignancies in Dominica: a seroprevalence study.
Adedayo OA; Shehu SM
Am J Hematol; 2004 Dec; 77(4):336-9. PubMed ID: 15551358
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of Japan.
Iwanaga M; Takada K; Fujiwara S; Oikawa O; Sugiura M; Imai S; Osato T; Mikuni C; Maekawa I; Miyazaki T
In Vivo; 1994; 8(6):1007-10. PubMed ID: 7772727
[TBL] [Abstract][Full Text] [Related]
28. Human T-lymphotropic virus and transfusion safety: does one size fit all?
Marano G; Vaglio S; Pupella S; Facco G; Catalano L; Piccinini V; Liumbruno GM; Grazzini G
Transfusion; 2016 Jan; 56(1):249-60. PubMed ID: 26388300
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safety.
Diarra AB; Kouriba B; Guindo A; Maiga AI; Diabaté DT; Douyon I; Diawara SI; Touré BA; Fonkoro S; Murphy EL; Diallo DA
Transfus Clin Biol; 2014 Jun; 21(3):139-42. PubMed ID: 24948205
[No Abstract] [Full Text] [Related]
30. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
Niazi SK; Bhatti FA; Salamat N
J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
[TBL] [Abstract][Full Text] [Related]
31. [SHTLV-I/II seroprevalence in blood donors of Hospital Pablo Tobón Uribe Blood Bank during the period 2014-2015].
Muñoz M; Carvalho S; Donado JH; Barco GE; Jaramillo S
Biomedica; 2018 Mar; 38(1):37-41. PubMed ID: 29668132
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence and demographic characteristics of HTLV-I among blood donors in Taiwan: 1996-1999.
Lu SC; Kao CL; Chin LT; Chen JW; Yang CM; Chang JH; Hsu SC; Chang AC; Chen BH
Int J Hematol; 2001 Oct; 74(3):333-7. PubMed ID: 11721972
[TBL] [Abstract][Full Text] [Related]
33. Trends in HTLV-1 prevalence and incidence of adult T-cell leukemia/lymphoma in Nagasaki, Japan.
Koga Y; Iwanaga M; Soda M; Inokuchi N; Sasaki D; Hasegawa H; Yanagihara K; Yamaguchi K; Kamihira S; Yamada Y
J Med Virol; 2010 Apr; 82(4):668-74. PubMed ID: 20166187
[TBL] [Abstract][Full Text] [Related]
34. Risk acceptance of human T-lymphotropic virus infection in solid organ transplantation-A survey of Atlantic Canadian ambulatory patients.
Patriquin G; Hatchette JE; Hatchette TF
Transpl Infect Dis; 2018 Oct; 20(5):e12958. PubMed ID: 29959880
[TBL] [Abstract][Full Text] [Related]
35. [Human T-cell lymphotropic virus in family members of seropositive blood donors: silent dissemination].
Catalan-Soares B; Carneiro-Proietti AB; Proietti FA;
Rev Panam Salud Publica; 2004 Dec; 16(6):387-94. PubMed ID: 15682520
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concern.
Biglione MM; Astarloa L; Salomón HE;
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):1-4. PubMed ID: 15665638
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
[TBL] [Abstract][Full Text] [Related]
38. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].
Rolo Gómez F; De Armas MB; Mato Luis J; Lubián Caballero AL; Díaz Torres H
Rev Cubana Med Trop; 1997; 49(3):204-8. PubMed ID: 9685988
[TBL] [Abstract][Full Text] [Related]
39. Current status of HTLV-1 infection.
Watanabe T
Int J Hematol; 2011 Nov; 94(5):430-4. PubMed ID: 21969187
[TBL] [Abstract][Full Text] [Related]
40. Human T-lymphotropic virus type I screening in volunteer blood donors--United States, 1989.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1990 Dec; 39(50):915, 921-4. PubMed ID: 1979140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
